Instrument Inactif

Autres langues Cell Source, Inc. Other OTC

Actions

CLCS

US15114L1044

Recherche biotechnologique et médicale

Autres langues

21/05	Cell Source Presented Its Breakthrough Developments for Mismatched Donor Stem Cell and Organ Transplants and Off-the-shelf CAR-T Cell Therapy at the LD Micro Invitational Conference in Los Angeles This Week
14/05	Cell Source, Inc. to Present at the LD Micro Invitational XVI
14/05	Cell Source : Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q)
14/05	Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
07/04	Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
07/04	Cell Source : Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K)
07/04	Cell Source, Inc. Auditor Raises 'Going Concern' Doubt
15/01	Cell Source, Inc. announced that it has received $1.5 million in funding
21/11/24	Cell Source, Inc. Shared Positive Interim Results from Its Phase 1/2 First-In-Human Clinical Trial Conducted At the University of Texas Md Anderson Cancer Center
14/11/24	Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
19/08/24	Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
29/07/24	Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
24/06/24	Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
24/06/24	Cell Source, Inc. Auditor Raises 'Going Concern' Doubt
22/03/24	Cell Source, Inc. announced that it has received $4.76017 million in funding
09/11/23	Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
19/09/23	Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23/08/23	Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
08/08/23	Cell Source, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
08/12/22	Note 2 - Going Concern and Management Plans
08/12/22	Cell Source, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
02/12/22	Note 2 - Going Concern and Management Plans
02/12/22	Cell Source, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
02/11/22	Note 2 - Going Concern and Management Plans
02/11/22	Cell Source, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022